Masimo Corp. (NASDAQ:MASI) reported preliminary 2025 results that landed at the high end of its guidance, signaling a successful first year under the leadership of Chief Executive Officer Katie Szyman.
The medical technology firm saw its revenue climb to approximately $1.52 billion, a 9% increase that reflects robust demand for its hospital monitoring systems despite the headwind of global tariffs.
For the fourth quarter, the Irvine, California-based company expects revenue of approximately $411 million, representing 12% growth on a reported basis.
More significantly, Masimo’s preliminary non-GAAP earnings per share (EPS) of more than $1.54 for the quarter helped push its full-year EPS to over $5.55.
This result matches the ceiling of the company’s raised November outlook, even as it absorbed the costs of a multi-front trade war.
The performance marks a pivotal stabilization for Masimo following a tumultuous 2024, which saw the ousting of founder Joe Kiani after a bitter proxy battle with activist firm Politan Capital Management.
Under the new board and Szyman’s direction, the company has divested its consumer audio business, Sound United, and refocused on its high-margin professional healthcare segment.